Tag Archives: Chronic

FDA Approves Imbruvica (ibrutinib) Plus Obinutuzumab as First Non-Chemotherapy Combination Regimen for Treatment-Naïve Patients with Chronic Lymphocytic Leukemia

Print this page HORSHAM, Pa., Jan. 28, 2019 /PRNewswire/ — The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food and Drug Administration (FDA) approval of Imbruvica (ibrutinib) in combination with obinutuzumab in treatment-naïve patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), the most common form of leukemia in adults.1 This is… Read More »

Chronic Wasting Disease In Tennessee, That Makes 24 States Potentially With 'Zombie' Deer

What will happen to CWD and the deer population in 2019? (Photo: Getty Images)Getty This has been a tough time for deer, and it has nothing to do with hauling a jolly big guy and presents on a sleigh. Back in January, I wrote for Forbes about how chronic wasting disease (CWD), otherwise known non-affectionately… Read More »

FDA Approves Motegrity (prucalopride) for Adults with Chronic Idiopathic Constipation (CIC)

FDA Approves Motegrity (prucalopride) for Adults with Chronic Idiopathic Constipation (CIC) Print this page Cambridge, Mass. – December 17, 2018 – Shire plc (LSE: SHP, NASDAQ: SHPG) has announced that the U.S. Food and Drug Administration (FDA) has approved Motegrity™ (prucalopride), a once-daily, oral treatment option for adults with Chronic Idiopathic Constipation (CIC).1 Motegrity, a… Read More »

Study finds chronic fatigue clues in overactive immune response

By Health and Science Correspondent Kate Kelland LONDON (Reuters) – Scientists exploring what may trigger a complex disorder known as chronic fatigue syndrome (CFS) have found clues in the way some people’s immune systems respond more actively to a health attack. A severe illness characterized by long-term physical and mental fatigue, CFS is thought to… Read More »

  1. Pages:
  3. 1
  4. 2
  5. 3